000860.SZ
Last
- - (-%)Time
-Previous Close
-
Open
-High
-Low
-
Latest News
AstraZeneca to seek accelerated approval of Ultomirisin in IgAN on Phase III data
published on April 22, 2026, 11:30 am (via Clinical Trials Arena)
Related Stocks
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.